Estonian medtech Better Medicine raises €1M to accelerate rollout of AI kidney cancer tool

▤ Summary

Better Medicine raised €1 million in a pre-seed round to expand its AI kidney cancer detection tool across Europe and prepare for U.S. clinical pilots. The company will use the capital to pursue FDA clearance and increase deployment of its CE-certified product, BMVision Kidney. The software helps radiologists detect malignant lesions in CT scans and aims to reduce diagnostic bottlenecks and workload pressure. The round included Soulmates Ventures, Specialist VC, UT Ventures, and angel investors, bringing the company’s total funding above €5 million. Better Medicine also positions the product for direct clinical integration in healthcare workflows.

$ Funding

▦ Linked Companies